Quantcast
Last updated on April 24, 2014 at 14:55 EDT

Latest 1,5-Anhydroglucitol Stories

2012-10-16 11:26:05

MILPITAS, Calif., Oct. 16, 2012 /PRNewswire/ -- A new study suggests that blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in type 2 diabetes patients who do not take insulin. The study is published online in Diabetes Technology & Therapeutics and appeared in the publication's September print issue. The preliminary study findings were based on a retrospective analysis of health insurance data and was led by Dr. Naunihal Virdi, Medical...

2011-09-27 14:59:38

Doctor-patient encounters associated with lower blood glucose, cholesterol and blood pressure levels in patients with diabetes The risk for diabetes complications, such as heart attack and stroke, increases with high blood glucose, blood pressure and cholesterol levels. Reducing risk means reducing these values to ideal levels. According to researchers at Brigham and Women's Hospital (BWH), achieving ideal levels may be as simple as seeing your doctor. They found that frequent...

2010-06-08 15:03:00

WINSTON-SALEM, N.C., June 8 /PRNewswire/ -- The "gold standard" diabetes test, Hemoglobin A1c (A1C), explains much less about the risk of cardiovascular complications in patients with diabetes than originally thought, according to an article in the June 9 issue of the Journal of the American Medical Association (JAMA). The article entitled, "Beyond HbA1c: Need for Additional Markers of Risk for Diabetic Microvascular Complications," was co-authored by Irl Hirsch, M.D., of the University...

2009-10-13 17:56:00

CARLSBAD, Calif., Oct. 13 /PRNewswire/ -- Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous' automated blood glucose monitor. Luminous is developing its monitor to enable clinicians to control hyperglycemia in critical care patients around the world. Previously, Luminous was planning to use a sensing technology based on near-infrared spectrometry....

2009-06-08 17:00:00

- Year-Long Phase 2 Diabetes Study Results Presented at ADA Annual Meeting - NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, today announced that data from a year-long phase 2 trial (DM-230) evaluating Qnexa(TM) in patients with type 2 diabetes are being highlighted in an oral podium presentation at the American Diabetes...

2009-04-28 09:00:00

BANNOCKBURN, Ill., April 28 /PRNewswire/ -- Healthy Life Laboratories has announced the release of its first iPhone Application for use by diabetes patients and healthcare professionals - the A1c Converter. This application, the first of its kind for use on iPhone and iPod Touch systems, is designed to help diabetics better understand the relationship between blood glucose and hemoglobin A1c. Maintaining good blood glucose control is essential for diabetics. Home glucose meters provide...

2008-07-17 09:01:20

NEW YORK and WINSTON-SALEM, N.C., July 17 /PRNewswire/ -- Toyota Tsusho America, Inc. (New York, NY) and Nippon Kayaku Co., Ltd. (Tokyo, Japan) announced today the formation of a new joint venture company, GlycoMark, Inc., dedicated to the discovery and commercialization of novel biomarkers for diabetes. The company is located in New York, NY and the Piedmont Triad Research Park in Winston-Salem, NC. Toyota Tsusho America, Inc., Nippon Kayaku Co., Ltd., and the BioMarker Group...